FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

JW Kupiec-Weglinski

Research Profile

Procedures

Living Beings

Physiology

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Stephan Korom; Ingrid De Meester; Elizabeth W Maas; A Stein; Sigrid Wilker; F Jung; Rolf Weimer; Mathias D Brendel; Wolfgang Ernst; S Friemann; R Linder; Helmut Grimm; Winfried Padberg; Simon Scharpé; JW Kupiec-Weglinski; Konrad Schwemmle
CD26 expression and enzymatic activity in recipients of kidney allografts.
Thomas H W Stadlbauer; Meike Schaub; C C Magee; JW Kupiec-Weglinski; Mohamed H Sayegh
Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Stephan Korom; Ingrid De Meester; AJ Coito; E Graser; Johann Pratschke; S König; Helmut Grimm; Hans-Dieter Volk; Simon Scharpé; JW Kupiec-Weglinski
CD26/DPP IV-mediated modulation of acute rejection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of JW Kupiec-Weglinski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Stephan Korom; Ingrid De Meester; Elizabeth W Maas; A Stein; Sigrid Wilker; F Jung; Rolf Weimer; Mathias D Brendel; Wolfgang Ernst; S Friemann; R Linder; Helmut Grimm; Winfried Padberg; Simon Scharpé; JW Kupiec-Weglinski; Konrad Schwemmle
CD26 expression and enzymatic activity in recipients of kidney allografts.
Transplantation proceedings 2002;34(5):1753-4.
2000: Thomas H W Stadlbauer; Meike Schaub; C C Magee; JW Kupiec-Weglinski; Mohamed H Sayegh
Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2000;19(6):566-75.
1999: Stephan Korom; Ingrid De Meester; AJ Coito; E Graser; Johann Pratschke; S König; Helmut Grimm; Hans-Dieter Volk; Simon Scharpé; JW Kupiec-Weglinski
CD26/DPP IV-mediated modulation of acute rejection.
Transplantation proceedings 1999;31(1-2):873.
1999: Stephan Korom; Ingrid De Meester; Georg Schmidbauer; Johann Pratschke; Mathias D Brendel; Christine Durinx; Konrad Schwemmle; Achiel Haemers; Simon Scharpé; JW Kupiec-Weglinski
Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity.
Transplantation proceedings 1999;31(1-2):778.
1998: K Onodera; H D Volk; T Ritter; JW Kupiec-Weglinski
Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):5765-72.
1998: H Kato; K Onodera; Anil Chandraker; Hans-Dieter Volk; Mohamed H Sayegh; JW Kupiec-Weglinski
CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients.
Transplantation proceedings 1998;30(4):1063-4.
1998: AJ Coito; Stephan Korom; Wayne W Hancock; JW Kupiec-Weglinski
Blockade of alpha 4 beta 1-integrin-fibronectin adhesive interactions prevents chronic allograft rejection in sensitized recipients.
Transplantation proceedings 1998;30(4):939-40.
1998: Stephan Korom; Wayne W Hancock; AJ Coito; JW Kupiec-Weglinski
Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients. II. Treatment with connecting segment-1 peptides prevents chronic rejection by attenuating arteriosclerotic development and suppressing intragraft T cell and macrophage activation.
Transplantation 1998;65(6):854-9.
1998: AJ Coito; Stephan Korom; E Graser; Hans-Dieter Volk; Livingston Van De Water; JW Kupiec-Weglinski
Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expression.
Transplantation 1998;65(5):699-706.
1998: K Onodera; Anil Chandraker; Stephan Korom; Thomas H W Stadlbauer; K Kato; S Kasai; Mohamed H Sayegh; JW Kupiec-Weglinski
Agonistic and antagonistic interactions between CTLA4Ig and donor alloantigens in sensitized rat recipients of cardiac allografts.
Transplantation proceedings 1998;30(1):16-8.
1998: K Onodera; Anil Chandraker; Hans-Dieter Volk; M Lehmann; Stephan Korom; Thomas H W Stadlbauer; K Kato; S Kasai; Mohamed H Sayegh; JW Kupiec-Weglinski
Role of regulatory T cells in the "infectious" tolerance pathway in transplant recipients.
Transplantation proceedings 1998;30(1):13-5.
1997: Thomas H W Stadlbauer; Meike Schaub; Stephan Korom; K Onodera; Mohamed H Sayegh; JW Kupiec-Weglinski
CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
Transplantation 1997;64(12):1816-22.
1997: JW Kupiec-Weglinski; A J Colto; Livingston Van De Water
Extracellular matrix proteins and their interactions with the cellular repertoire of transplant recipients.
Transplantation proceedings 1997;29(6):2601-2.
1997: K Onodera; Anil Chandraker; Meike Schaub; Thomas H W Stadlbauer; Stephan Korom; Robert Peach; Peter Linsley; Mohamed H Sayegh; JW Kupiec-Weglinski
CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(4):1711-7.
1997: Stephan Korom; Ingrid De Meester; Thomas H W Stadlbauer; Anil Chandraker; Meike Schaub; Mohamed H Sayegh; A Belyaev; Achiel Haemers; Simon Scharpé; JW Kupiec-Weglinski
Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients.
Transplantation 1997;63(10):1495-500.
1997: Thomas H W Stadlbauer; JW Kupiec-Weglinski
Immunobiology of sensitization in transplant recipients.
The American journal of the medical sciences 1997;313(5):268-74.
1997: K Onodera; M Lehmann; Hans-Dieter Volk; Mohamed H Sayegh; JW Kupiec-Weglinski
CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
Transplantation proceedings 1997;29(3):1907-8.
1997: AJ Coito; Lawrence F Brown; John H Peters; JW Kupiec-Weglinski; Livingston Van De Water
Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.
The American journal of pathology 1997;150(5):1757-72.
1997: K Onodera; Wayne W Hancock; E Graser; M Lehmann; Mohamed H Sayegh; Terry B Strom; Hans-Dieter Volk; JW Kupiec-Weglinski
Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(4):1572-81.
1997: K Onodera; Wayne W Hancock; E Graser; Hans-Dieter Volk; M Lehmann; Anil Chandraker; Mohamed H Sayegh; JW Kupiec-Weglinski
Th2-type cytokines in the "infectious" tolerance pathway.
Transplantation proceedings 1997;29(1-2):1290-1.
1997: Stephan Korom; Ingrid De Meester; K Onodera; Thomas H W Stadlbauer; M Borloo; Anne-Marie Lambeir; JW Kupiec-Weglinski
The effects of CD26/DPP IV-targeted therapy on acute allograft rejection.
Transplantation proceedings 1997;29(1-2):1274-5.
1997: AJ Coito; Stephan Korom; Livingston Van De Water; JW Kupiec-Weglinski
Distinct fibronectin splicing variants: potential targets for therapeutic immunomodulation in organ allograft recipients.
Transplantation proceedings 1997;29(1-2):1060-1.
1997: Thomas H W Stadlbauer; K Onodera; Meike Schaub; Stephan Korom; J Binder; Mohamed H Sayegh; JW Kupiec-Weglinski
Intrathymic immunomodulation of sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Transplantation proceedings 1997;29(1-2):1016.
1997: Georg Schmidbauer; A Homeyer; R M Bohle; Helmut Grimm; J Binder; JW Kupiec-Weglinski
Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
Transplantation proceedings 1997;29(1-2):607-8.
1997: Barbara A Wasowska; Wayne W Hancock; K Onodera; Stephan Korom; Thomas H W Stadlbauer; Xin Xiao Zheng; Terry B Strom; JW Kupiec-Weglinski
Rapamycin and cyclosporine A treatment: a novel regimen to prevent chronic allograft rejection in sensitized hosts.
Transplantation proceedings 1997;29(1-2):333.
1996: K Onodera; M Lehmann; Enver Akalin; Hans-Dieter Volk; Mohamed H Sayegh; JW Kupiec-Weglinski
Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(5):1944-50.
1996: J Binder; M Lehmann; E Graser; Wayne W Hancock; B Watschinger; K Onodera; Mohamed H Sayegh; Hans-Dieter Volk; JW Kupiec-Weglinski
The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Transplantation 1996;61(5):804-11.
1996: AJ Coito; JW Kupiec-Weglinski
Extracellular matrix proteins: bystanders or active participants in the allograft rejection cascade?
Annals of transplantation : quarterly of the Polish Transplantation Society 1996;1(3):14-8.
1996: Barbara A Wasowska; K J Wieder; Wayne W Hancock; Xin Xiao Zheng; Brygida Berse; J Binder; Terry B Strom; JW Kupiec-Weglinski
Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(1):395-404.
1995: J Binder; E Graser; Wayne W Hancock; Barbara A Wasowska; Mohamed H Sayegh; Hans-Dieter Volk; JW Kupiec-Weglinski
Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients.
Transplantation 1995;60(12):1516-24.
1995: AJ Coito; J Binder; Lawrence F Brown; M de Sousa; Livingston Van De Water; JW Kupiec-Weglinski
Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(6):2949-58.
1995: J Binder; Wayne W Hancock; B Watschinger; Barbara A Wasowska; Mohamed H Sayegh; JW Kupiec-Weglinski
The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
Transplantation 1995;59(4):590-7.
1995: AJ Coito; J Binder; Lawrence F Brown; M de Sousa; Livingston Van De Water; JW Kupiec-Weglinski
TNF-alpha upregulates the expression of fibronectin in acutely rejecting rat cardiac allografts.
Transplantation proceedings 1995;27(1):463-5.
1995: Georg Schmidbauer; Wayne W Hancock; Barbara A Wasowska; J Binder; Winfried Padberg; JW Kupiec-Weglinski
Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
Transplantation proceedings 1995;27(1):427-9.
1995: Barbara A Wasowska; K J Wieder; Wayne W Hancock; Brygida Berse; J Binder; Terry B Strom; JW Kupiec-Weglinski
Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
Transplantation proceedings 1995;27(1):423-6.
1995: J Binder; Wayne W Hancock; B Watschinger; Barbara A Wasowska; Mohamed H Sayegh; JW Kupiec-Weglinski
Abrogation of accelerated allograft rejection by intrathymic injection of donor spleen cells is associated with upregulation of donor-reactive IgM, IgG1, and IgG2A, but depression of IgG2B in the circulation and at the graft site.
Transplantation proceedings 1995;27(1):138-41.
1995: J Binder; Wayne W Hancock; Barbara A Wasowska; L Gallon; B Watschinger; Mohamed H Sayegh; J Brock; M Lehmann; Hans-Dieter Volk; JW Kupiec-Weglinski
Donor-specific transplantation unresponsiveness in sensitized rats following treatment with a nondepleting anti-CD4 MAb is associated with selective intragraft sparing of Th2-like cells.
Transplantation proceedings 1995;27(1):114-6.
1994: J Binder; Elena Mishina; William J Jusko; JW Kupiec-Weglinski
Prolongation of cardiac allograft survival in rats by liposome-encapsulated methylprednisolone.
Transplantation 1994;58(5):633-5.
1994: J Binder; Mohamed H Sayegh; B Watschinger; Wayne W Hancock; JW Kupiec-Weglinski
Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
Transplantation 1994;58(1):80-6.
1994: AJ Coito; M De Sousa; JW Kupiec-Weglinski
The role of cellular and extracellular matrix adhesion proteins in organ transplantation.
Cell adhesion and communication 1994;2(3):249-55.
1994: Georg Schmidbauer; Wayne W Hancock; Barbara A Wasowska; A M Badger; JW Kupiec-Weglinski
Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
Transplantation 1994;57(6):933-41.
1994: AJ Coito; J Binder; M de Sousa; JW Kupiec-Weglinski
The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats.
Transplantation 1994;57(4):599-605.
1993: JW Kupiec-Weglinski; Barbara A Wasowska; I Papp; Georg Schmidbauer; Mohamed H Sayegh; William M Baldwin; K J Wieder; Wayne W Hancock
CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(9):5053-61.
1993: W D Whitley; Wayne W Hancock; JW Kupiec-Weglinski; M DeSousa; Nicholas L Tilney
Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats.
Transplantation 1993;56(5):1182-8.
1993: K J Wieder; Wayne W Hancock; Georg Schmidbauer; C L Corpier; I Wieder; L Kobzik; Terry B Strom; JW Kupiec-Weglinski
Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(2):1158-66.
1993: Georg Schmidbauer; Wayne W Hancock; A M Badger; JW Kupiec-Weglinski
Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
Transplantation 1993;55(6):1236-43.
1993: JW Kupiec-Weglinski; U W Heemann; AJ Coito; Stefan G Tullius; Nicholas L Tilney; M de Sousa
Adhesion molecule interaction with extracellular matrix.
Experimental nephrology 1993;1(2):78-82.
1993: Georg Schmidbauer; Wayne W Hancock; Barbara A Wasowska; T Sablinski; JW Kupiec-Weglinski
Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
Transplantation proceedings 1993;25(1 Pt 1):712-3.
1993: T Sablinski; Wayne W Hancock; Barbara A Wasowska; Georg Schmidbauer; William M Baldwin; J P Kut; E L Milford; JW Kupiec-Weglinski
Modulation of acute and hyperacute rejection of xenografts in concordant hamster-to-rat combination.
Transplantation proceedings 1993;25(1 Pt 1):432-4.
1993: Georg Schmidbauer; Wayne W Hancock; A M Badger; JW Kupiec-Weglinski
SK&F 105685 treatment induces suppressor cell activity and modulates cell adhesion properties in rat recipients of cardiac allografts.
Transplantation proceedings 1993;25(1 Pt 1):758-60.
1992: K Tanaka; Nicholas L Tilney; JW Kupiec-Weglinski
Maturing thymocytes in accelerated rejection of cardiac allografts in presensitized rats.
Transplantation 1992;54(3):515-9.
1992: T Sablinski; Mohamed H Sayegh; J P Kut; E L Milford; Nicholas L Tilney; JW Kupiec-Weglinski
Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms.
Transplantation 1992;54(2):292-6.
1992: Wayne W Hancock; Mohamed H Sayegh; T Sablinski; J P Kut; JW Kupiec-Weglinski; E L Milford
Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
Transplantation 1992;53(6):1276-80.
1992: T Sablinski; Wayne W Hancock; Georg Schmidbauer; E L Milford; JW Kupiec-Weglinski
CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.
Transplantation proceedings 1992;24(2):528-30.
1992: I Papp; K J Wieder; T Sablinski; Philip J O'Connell; E L Milford; Terry B Strom; JW Kupiec-Weglinski
Evidence for functional heterogeneity of rat CD4+ T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(5):1308-14.
1992: Wayne W Hancock; Georg Schmidbauer; A M Badger; JW Kupiec-Weglinski
SK&F 105685 suppresses allogeneically induced mononuclear and endothelial cell activation and cytokine production and prolongs rat cardiac allograft survival.
Transplantation proceedings 1992;24(1):231-2.
1992: Wayne W Hancock; D Whitley; JW Kupiec-Weglinski; Nicholas L Tilney
Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival.
Transplantation proceedings 1992;24(1):214-5.
1992: T Sablinski; Mohamed H Sayegh; J P Kut; Nicholas L Tilney; E L Milford; JW Kupiec-Weglinski
The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival.
Transplantation 1992;53(1):219-21.
1991: T Sablinski; Wayne W Hancock; Nicholas L Tilney; JW Kupiec-Weglinski
CD4 monoclonal antibodies in organ transplantation--a review of progress.
Transplantation 1991;52(4):579-89.
1991: H Ueda; Y C Cheung; P Masetti; M Diaco; M McCarter; JW Kupiec-Weglinski; Nicholas L Tilney; M Martin
Synergy between cyclosporine and anti-IL-2 receptor monoclonal antibodies in rats. Functional studies of heart and kidney allografts.
Transplantation 1991;52(3):437-42.
1991: Nicholas L Tilney; W D Whitley; JR Diamond; JW Kupiec-Weglinski; D H Adams
Chronic rejection--an undefined conundrum.
Transplantation 1991;52(3):389-98.
1991: JW Kupiec-Weglinski; M De Sousa
Lymphocyte traffic is modified in vivo by anti-laminin antibody.
Immunology 1991;72(2):312-3.
1991: JW Kupiec-Weglinski; T Sablinski; Wayne W Hancock; C T Mix; Nicholas L Tilney
Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
Transplantation proceedings 1991;23(1 Pt 1):285-6.
1991: K Tanaka; JW Kupiec-Weglinski; W W Hancock; K Stunkel; T Diamantstein; N L Tilney
Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
Transplantation proceedings 1991;23(1 Pt 1):281-2.
1991: T Sablinski; Mohamed H Sayegh; J P Kut; Wayne W Hancock; E L Milford; Nicholas L Tilney; JW Kupiec-Weglinski
Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
Transplantation proceedings 1991;23(1 Pt 1):268-9.
1991: JW Kupiec-Weglinski; T Sablinski; Wayne W Hancock; R Di Stefano; G Mariani; C T Mix; Nicholas L Tilney
Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy.
Transplantation 1991;51(2):300-5.
1991: Mohamed H Sayegh; T Sablinski; K Tanaka; J P Kut; C A Kwok; Nicholas L Tilney; JW Kupiec-Weglinski; E L Milford
Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment.
Transplantation 1991;51(2):296-9.
1991: T Sablinski; Mohamed H Sayegh; Wayne W Hancock; J P Kut; C A Kwok; E L Milford; Nicholas L Tilney; JW Kupiec-Weglinski
Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection.
Transplantation 1991;51(1):226-31.
1990: H Ueda; Wayne W Hancock; Y C Cheung; T Diamantstein; Nicholas L Tilney; JW Kupiec-Weglinski
The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.
Transplantation 1990;50(4):545-50.
1990: Koichi Tanaka; L A Turka; JW Kupiec-Weglinski; E L Milford; H Ueda; T Diamantstein; Charles B Carpenter; Nicholas L Tilney
Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture.
Transplantation 1990;50(1):125-31.
1990: H Ueda; Wayne W Hancock; Y C Cheung; Koichi Tanaka; JW Kupiec-Weglinski; Nicholas L Tilney
Differential effects of interleukin 2 receptor-targeted therapy on heart and kidney allografts in rats. Depression of effectiveness of ART-18 monoclonal antibody treatment by uremia.
Transplantation 1990;49(6):1124-9.
1989: K Tanaka; Wayne W Hancock; H Osawa; K G Stunkel; T V Alberghini; T Diamantstein; Nicholas L Tilney; JW Kupiec-Weglinski
Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(9):2873-9.
1989: JW Kupiec-Weglinski; G Mariani; K Tanaka; R Di Stefano; K G Stünkel; T Diamantstein; Nicholas L Tilney
Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation.
Cellular immunology 1989;123(1):148-57.
1989: T Diamantstein; JW Kupiec-Weglinski; Terry B Strom; N L Tilney
Current stage of interleukin 2 receptor targeted therapy.
Experimental and clinical endocrinology 1989;93(2-3):114-24.
1989: JW Kupiec-Weglinski; Nicholas L Tilney
Lymphocyte migration patterns in organ allograft recipients.
Immunological reviews 1989;108():63-82.
1989: R DiStefano; L C Uhteg; Wayne W Hancock; D Araneda; JW Kupiec-Weglinski; Nicholas L Tilney
Host-graft relationship in accelerated rejection of rat cardiac allografts.
Transplantation proceedings 1989;21(1 Pt 1):496-7.
1989: R H Lord; Winfried Padberg; Wayne W Hancock; JW Kupiec-Weglinski; Nicholas L Tilney
Correlation of macrophage and NK cell numbers with "activation markers" in rat cardiac allografts.
Transplantation proceedings 1989;21(1 Pt 1):449-50.
1989: Koichi Tanaka; L A Turka; H Ueda; T Diamantstein; E L Milford; Charles B Carpenter; Nicholas L Tilney; JW Kupiec-Weglinski
Selective sparing of T suppressor cells by anti interleukin-2 receptor monoclonal antibodies (IL-2R mAbs) in vitro correlates with their therapeutic effects in vivo.
Transplantation proceedings 1989;21(1 Pt 1):475-6.
1989: Nicholas L Tilney; JW Kupiec-Weglinski
Advances in the understanding of rejection mechanisms.
Transplantation proceedings 1989;21(1 Pt 1):10-3.
1989: Laurence A Turka; K Tanaka; JW Kupiec-Weglinski; E L Milford; Nicholas L Tilney; Charles B Carpenter
In vivo activity of mixed lymphocyte response-generated suppressor cells and ability to prolong cardiac allograft survival in rats.
Transplantation 1989;47(2):388-90.
1989: JW Kupiec-Weglinski; P van der Meide; K G Stunkel; Koichi Tanaka; T Diamantstein; Nicholas L Tilney
Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network.
Transplantation proceedings 1989;21(1 Pt 1):992-3.
1989: JW Kupiec-Weglinski; Nicholas L Tilney; K G Stunkel; R Grutzmann; P H van der Meide; R Di Stefano; T Diamantstein
Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts.
Transplantation 1989;47(1):11-6.
1988: JW Kupiec-Weglinski; T Diamantstein; Nicholas L Tilney
Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation.
Transplantation 1988;46(6):785-92.
1988: Nicholas L Tilney; Winfried Padberg; R H Lord; D Araneda; Terry B Strom; JW Kupiec-Weglinski
Synergy between subtherapeutic doses of cyclosporine and immunobiological manipulations in rat heart graft recipients.
Transplantation 1988;46(2 Suppl):122S-128S.
1988: Nicholas L Tilney; Terry B Strom; JW Kupiec-Weglinski
Pharmacologic and immunologic agonists and antagonists of cyclosporine.
Transplantation proceedings 1988;20(3 Suppl 3):13-22.
1988: Winfried Padberg; R H Lord; D Araneda; Nicholas L Tilney; JW Kupiec-Weglinski
Synergistic immunosuppressive effect of subtherapeutic doses of cyclosporine A on immunologic enhancement in rat recipients of cardiac allografts.
Transplantation proceedings 1988;20(3 Suppl 3):1053-6.
1988: R Di Stefano; A Mouzaki; D Araneda; T Diamantstein; Nicholas L Tilney; JW Kupiec-Weglinski
Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.
The Journal of experimental medicine 1988;167(6):1981-6.
1988: R H Lord; Winfried Padberg; R Di Stefano; Wayne W Hancock; D Araneda; F R Rickles; Nicholas L Tilney; JW Kupiec-Weglinski
Immunohistologic profile of cells infiltrating acutely rejecting and long-surviving rat cardiac allografts.
Transplantation proceedings 1988;20(2):229-30.
1988: R DiStefano; JW Kupiec-Weglinski; L C Uhteg; J Puskas; D Araneda; T Diamantstein; Nicholas L Tilney
Modulation of accelerated rat cardiac allograft rejection by cyclosporine and ART-18.
Transplantation proceedings 1988;20(2 Suppl 2):217-22.
1988: JW Kupiec-Weglinski; Hans-Jürgen Hahn; R L Kirkman; Hans-Dieter Volk; A Mouzaki; R DiStefano; G Tellides; M Dallman; P J Morris; Terry B Strom
Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
Transplantation proceedings 1988;20(2 Suppl 2):207-16.
1988: JW Kupiec-Weglinski; R Di Stefano; K G Stunkel; R Grutzmann; P Theisen; D Araneda; Nicholas L Tilney; T Diamantstein
Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
Transplantation proceedings 1988;20(1 Suppl 1):272-5.
1988: Winfried Padberg; R H Lord; R Di Stefano; D Araneda; Nicholas L Tilney; JW Kupiec-Weglinski
Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allografts.
Transplantation 1988;45(1):162-8.
1988: T Diamantstein; A Mouzaki; H Osawa; Hans-Dieter Volk; Hans-Jürgen Hahn; R L Kirkman; Terry B Strom; N L Tilney; JW Kupiec-Weglinski
Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclonal antibodies and synergistic effect of cyclosporin A.
Developments in biological standardization 1988;69():177-84.
1987: Nicholas L Tilney; Terry B Strom; JW Kupiec-Weglinski
Humoral and cellular mechanisms in acute allograft injury.
The Journal of pediatrics 1987;111(6 Pt 2):1000-3.
1987: Winfried Padberg; K Schwemmle; J Dobroschke; JW Kupiec-Weglinski; Nicholas L Tilney
[Immunosuppressive therapy in transplantation surgery].
Deutsche medizinische Wochenschrift (1946) 1987;112(43):1670-4.
1987: Winfried Padberg; R Di Stefano; R H Lord; D Araneda; Terry B Strom; T Diamantstein; Nicholas L Tilney; JW Kupiec-Weglinski
Synergy between cyclosporine and other immunosuppressive regimens in experimental organ transplantation.
Transplantation proceedings 1987;19(5):4234-5.
1987: Winfried Padberg; R H Lord; JW Kupiec-Weglinski; J M Williams; R Di Stefano; L E Thornburg; D Araneda; Terry B Strom; Nicholas L Tilney
Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(6):1751-7.
1987: Winfried Padberg; JW Kupiec-Weglinski; R H Lord; D H Araneda; Nicholas L Tilney
W3/25+ T cells mediate the induction of immunologic unresponsiveness in enhanced rat recipients of cardiac allografts.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(11):3669-74.
1987: JW Kupiec-Weglinski; Winfried Padberg; L C Uhteg; L Ma; R H Lord; D Araneda; Terry B Strom; T Diamantstein; Nicholas L Tilney
Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
European journal of immunology 1987;17(3):313-9.
1987: Winfried Padberg; JW Kupiec-Weglinski; R H Lord; E Towpik; Nicholas L Tilney
W3/25+ T cells mediate specific unresponsiveness in enhanced allograft recipients.
Transplantation proceedings 1987;19(1 Pt 1):493-4.
1987: R H Lord; Wayne W Hancock; A J Colby; Winfried Padberg; T Diamantstein; JW Kupiec-Weglinski; Nicholas L Tilney
Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
Transplantation proceedings 1987;19(1 Pt 1):354-5.
1987: JW Kupiec-Weglinski; Winfried Padberg; L C Uhteg; E Towpik; R H Lord; L Ma; T Diamantstein; Terry B Strom; Nicholas L Tilney
Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
Transplantation proceedings 1987;19(1 Pt 1):591-3.
1987: E Towpik; JW Kupiec-Weglinski; L C Uhteg; Winfried Padberg; Nicholas L Tilney
Immune responsiveness following skin grafting in cyclosporine-treated rats.
Transplantation proceedings 1987;19(1 Pt 1):497-8.
1986: T M Schneider; JW Kupiec-Weglinski; E Towpik; Winfried Padberg; D Araneda; T Diamantstein; Terry B Strom; Nicholas L Tilney
Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
Transplantation 1986;42(2):191-6.
1986: T M Schneider; JW Kupiec-Weglinski; E Towpik; Terry B Strom; Nicholas L Tilney
Studies on mechanisms of acute rejection of vascularized organ allografts.
Human immunology 1986;15(3):320-9.
1985: E Towpik; JW Kupiec-Weglinski; T M Schneider; D Tyler; Winfried Padberg; D Araneda; Nicholas L Tilney
Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
Transplantation 1985;40(6):714-8.
1985: JW Kupiec-Weglinski; E Towpik; T M Schneider; D Araneda; L Ma; Nicholas L Tilney
T suppressor lymphocytes reverse ongoing acute allograft rejection.
Human immunology 1985;14(3):270-8.
1985: C D Heidecke; J L Araujo; JW Kupiec-Weglinski; M Abbud-Filho; D Araneda; J Stadler; J Siewert; Terry B Strom; Nicholas L Tilney
Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts.
Transplantation 1985;40(4):441-4.
1985: J L Araujo; JW Kupiec-Weglinski; D Araneda; E Towpik; C D Heidecke; J M Williams; Nicholas L Tilney
Phenotype, activation status, and suppressor activity of host lymphocytes during acute rejection and after cyclosporine-induced unresponsiveness of rat cardiac allografts.
Transplantation 1985;40(3):278-84.
1985: JW Kupiec-Weglinski; C D Heidecke; J L Araujo; M Abbud-Filho; E Towpik; D Araneda; Terry B Strom; Nicholas L Tilney
Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat.
Cellular immunology 1985;93(1):168-77.
1984: M Abbud-Filho; JW Kupiec-Weglinski; J L Araujo; C D Heidecke; Nicholas L Tilney; Terry B Strom
Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
Journal of immunology (Baltimore, Md. : 1950) 1984;133(5):2582-6.
1984: C D Heidecke; JW Kupiec-Weglinski; P A Lear; M Abbud-Filho; J L Araujo; D Araneda; Terry B Strom; Nicholas L Tilney
Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(2):582-8.
1984: JW Kupiec-Weglinski; P A Lear; C D Heidecke; Nicholas L Tilney
Modification of function and migration patterns of thymocyte populations by cyclosporine after organ transplantation in rats.
Transplantation 1984;37(6):631-3.
1984: JW Kupiec-Weglinski; P A Lear; C D Heidecke; D Araneda; Nicholas L Tilney
Restoration of allograft responsiveness in B rats. IV. The divergent migratory behavior of lymphocyte populations mediating cardiac allograft rejection.
Cellular immunology 1984;85(2):459-76.
1984: Nicholas L Tilney; JW Kupiec-Weglinski; C D Heidecke; P A Lear; Terry B Strom
Mechanisms of rejection and prolongation of vascularized organ allografts.
Immunological reviews 1984;77():185-216.
1983: P A Lear; C D Heidecke; JW Kupiec-Weglinski; D Araneda; Terry B Strom; Nicholas L Tilney
Restoration of allograft responsiveness in B rats. II. Requirements for lymphoid populations and lymphokine.
Transplantation 1983;36(4):412-7.